GO FUND IT NOW

National Institutes of Health

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing January 7, 2028.

Funder

National Institutes of Health

Funding

Grant / contract

Deadline

Jan 7, 2028

(525d left)

See if your org is a fit, start free

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) | Go Fund It Now